Pharmacokinetic and Immunological Considerations for Expanding the Therapeutic Window of Next-Generation Antibody–Drug Conjugates
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Thurber, Greg M.
Funding for this research was provided by:
Division of Chemical, Bioengineering, Environmental, and Transport Systems (1553860)
Text and Data Mining valid from 2018-08-21